The State University Awarded Grant for Cancer Research
Commission on Cancer Research | State of New JerseyState · Trenton, NJ- Document date
- Nov 13, 2024
The 30-second brief
The State University of New Jersey receives a grant for cancer research, focusing on CD74 receptor activated Paneth cells in intestinal inflammation and cancer progression.
The State University of New Jersey holds this grant contract with Commission on Cancer Research | State of New Jersey.
See every contract and contact at Commission on Cancer Research | State of New Jersey.
See every contractFree account · 30-second setup · No credit card
Contract details
- Contract type
- Grant
- Document date
- November 13, 2024
- Term
- NA
- Source document
- dr_anna_marie_skalka_8th_annual_cancer_research_sy.pdf (Agenda)
More Commission on Cancer Research | State of New Jersey contracts
Questions about this contract
Who was awarded the grant contract by Commission on Cancer Research | State of New Jersey?
The State University of New Jersey was awarded this grant contract by Commission on Cancer Research | State of New Jersey, as recorded on November 13, 2024.
What type of contract is this?
This is a Grant contract, documented as a agenda record.
Where was this contract approved?
This contract appears in dr_anna_marie_skalka_8th_annual_cancer_research_sy.pdf (Agenda), dated November 13, 2024 from Commission on Cancer Research | State of New Jersey. Civic IQ extracts contract records directly from agency meeting documents and solicitations.
What other contracts does The State University of New Jersey hold?
The State University of New Jersey may hold additional government contracts. View their full contract history, the agencies they serve, and total tracked spend on their Civic IQ vendor profile.
Show 1 more question
What is Commission on Cancer Research | State of New Jersey currently buying?
Explore Commission on Cancer Research | State of New Jersey's vendors, signed contracts, and active RFPs on their Civic IQ agency profile.